Springer Nature
Browse
13063_2017_1812_MOESM4_ESM.pdf (204.97 kB)

Additional file 4: of Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial

Download (204.97 kB)
journal contribution
posted on 2017-03-07, 05:00 authored by Amy Cranston, Deborah Stocken, Elaine Stamp, David Roblin, Julia Hamlin, James Langtry, Ruth Plummer, Alan Ashworth, John Burn, Neil Rajan
Pictorial overview of phase 2a design. (PDF 152 kb)

Funding

Health Innovation Challenge Fund, Wellcome Trust and Department of Health

History